Skip to content

Precigen PGEN Share-Based Payment Award Options Outstanding - Number

Share-Based Payment Award Options Outstanding - Number at other companies

Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
16.7M+18.6%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
6.6M+4.2%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's share-based payment award options outstanding - number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's share-based payment award options outstanding - number?
Precigen (PGEN) reported share-based payment award options outstanding - number of 28.2M in Q1 2026.
How has Precigen's share-based payment award options outstanding - number changed year-over-year?
Precigen's share-based payment award options outstanding - number increased by 9.1% year-over-year, from 25.9M to 28.2M.
What is the long-term trend for Precigen's share-based payment award options outstanding - number?
Over 3 years (2022 to 2025), Precigen's share-based payment award options outstanding - number has grown at a 22.8% compound annual growth rate (CAGR), from 15.2M to 28.2M.
What does share-based payment award options outstanding - number mean?
This is the total count of stock options granted to employees and directors that remain unexercised at the reporting date. It reflects the total volume of potential equity claims currently held by the workforce. This metric is a key component in calculating fully diluted share counts.